
TINA.org Supports FTC’s ‘Click to Cancel’ Rule against Industry Challenge
Companies should not be able to trap consumers into subscriptions that they do not want.
In January 2013, another class-action lawsuit was filed against Pfizer regarding its marketing of Zoloft. This time, the allegation is that the drug label and marketing materials do not mention the numerous clinical trials in which Zoloft was shown to be no more effective in treating depression than placebo. Instead, Pfizer’s consumers are given the impression that Zoloft is very effective for treating depression. (Plumlee v. Pfizer, Inc., Case No. 13-cv-00414, N.D. Cal.)
Companies should not be able to trap consumers into subscriptions that they do not want.
Getting out may not be as easy as signing up.
Ellen Lee, The New York Times
TINA.org discovers the evidence behind these weight-loss claims is slim.
Watch out for hidden fees.